Comparative genomics guides elucidation of vitamin B12 biosynthesis in novel human associated Akkermansia
Nina Kirmiz, Kadir Galindo, Karissa L. CrossiD, Estefani Luna, Nicholas S. RhoadesiD, Mircea PodariD, Gilberto E. FloresiD
Abstract
BackgroundAkkermansia muciniphila is a mucin-degrading bacterium found in the gut of most healthy humans and is considered a next-generation probiotic. However, knowledge of the genomic and physiological diversity of human associated Akkermansia is limited, as only one species has been formally described. ResultsTo begin to fill this knowledge gap, we reconstructed 35 high-quality metagenome assembled genomes from children and combined them with 40 other publicly available genomes from adults and mice for comparative genomic analysis. We identified at least four species-level phylogroups (AmI-AmIV) with distinct functional potentials. Most notably, we identified the presence of putative cobalamin (vitamin B12) biosynthesis genes within the AmII (n=26/28) and AmIII (n=2/2) phylogroups. To test these predictions, 10 novel strains of Akkermansia were isolated from adults and screened for essential vitamin B12 biosynthesis genes via PCR. Two strains of the AmII phylogroup were positive for the presence of vitamin B12 biosynthesis genes, while all AmI strains, including the type strain A. muciniphila MucT, were negative. To demonstrate vitamin B12 biosynthesis, we measured the production of acetate, succinate, and propionate in the presence and absence of vitamin supplementation in representative strains of the AmI and AmII phylogroups since cobalamin is a cofactor in propionate metabolism. Results show that the Akkermansia AmII strain produced acetate and propionate in the absence of supplementation, which is indicative of de novo vitamin B12 biosynthesis. In contrast, acetate and succinate were the main fermentation products for the AmI strains when vitamin B12 was not supplied in the culture medium. ConclusionsWe identified Akkermansia strains as potentially important vitamin B12 biosynthetic bacteria in the human gut. This novel physiological trait of human associated Akkermansia may impact how these bacteria interact with the human host and other members of the human gut microbiome.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 95
- FWCI
- 2.73
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gorse (Ulex europeaus) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B12 producing commensal gut microbes
A. Iyer, E. C. Soto-Martin, … W. R. Russell·bioRxiv·Aug 2, 2023
- Inverse association between serum vitamin B12 level and abundance of potential B12-producing gut microbes in Indian children
Nisha Chandel, Priyansh Patel, … Vivek Thakur·Journal of NutritionPeer-reviewed·Oct 13, 2025
- A thousand metagenome-assembled genomes of Akkermansia reveal new phylogroups and geographical and functional variations in human gut
Qingbo Lv, Shenghui Li, … Xiao‐Xuan Zhang·Frontiers in Cellular and Infection MicrobiologyPeer-reviewed·Aug 2, 2022
- High-throughput detection and quantification of vitamin B12 in microbiome isolates using Escherichia coli
Katarzyna Hencel, Matthew A. Sullivan, Alper Akay·bioRxiv·Apr 8, 2025
- Metabolic engineering of Escherichia coli for de novo biosynthesis of vitamin B12
Huan Fang, Dong Li, … Dawei Zhang·Nature CommunicationsPeer-reviewed·Nov 15, 2018
- Utilization efficiency of human milk oligosaccharides by human-associated Akkermansia is strain-dependent
E. Luna, S. G. Parkar, … G. E. Flores·Applied and Environmental MicrobiologyPeer-reviewed·Jan 11, 2022